Table 2 Prognostic factors for in-field control by Cox proportional-hazards model.
Variable | Univariable | Multivariable | ||
|---|---|---|---|---|
HR (95% CI) | p | HR (95% CI) | p | |
Tumor size (1 cm increase) | 1.22 (1.07–1.38) | 0.002 | 1.19 (1.05–1.34) | 0.006 |
Portal vein tumor thrombosis | 5.79 (1.51–22.3) | 0.011 | ||
AFP level, ≥200 vs. <200 | 3.81 (1.02–14.22) | 0.047 | ||
CTP class, A vs. B | 3.06 (0.38–24.70) | 0.294 | ||
EQD2 (Gy), >71.3 vs. ≤71.3 | 1.03 (0.28–3.88) | 0.963 | ||
1st MRI mRECIST response | ||||
responding lesion | 0.37 (0.10–1.41) | 0.145 | ||
Pre-SABR ADC (×10−3 mm2/s) | ||||
>1.45 vs. ≤1.45 | 1.77 (0.44–7.08) | 0.423 | ||
Post-SABR ADC change | ||||
any ADC increment | 0.75 (0.16–3.63) | 0.723 | ||
≥25% ADC increment | 0.09 (0.01–0.72) | 0.023 | 0.11 (0.01–0.88) | 0.037 |